Walleye Capital
AZN icon

Walleye Capital’s AstraZeneca AZN Stock Holding History

Walleye Capital’s Portfolio AZN Stock Details AZN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$6.8M Sell
34,500
-112,350
-77% -$21.7M 0.03% 605
2025
Q4 		$27M Buy
146,850
+72,500
+98% +$12.7M 0.08% 192
2025
Q3 		$11.4M Buy
74,350
+13,100
+21% +$1.98M 0.04% 484
2025
Q2 		$8.56M Sell
61,250
-2,800
-4% -$392K 0.03% 577
2025
Q1 		$9.42M Buy
64,050
+5,250
+9% +$760K 0.04% 470
2024
Q4 		$7.71M Sell
58,800
-57,700
-50% -$8.08M 0.02% 798
2024
Q3 		$18.2M Buy
116,500
+9,500
+9% +$1.53M 0.04% 376
2024
Q2 		$16.7M Sell
107,000
-12,600
-11% -$1.9M 0.03% 445
2024
Q1 		$16.2M Sell
119,600
-6,650
-5% -$881K 0.03% 538
2023
Q4 		$17M Buy
126,250
+12,100
+11% +$1.57M 0.04% 407
2023
Q3 		$15.5M Buy
114,150
+60,050
+111% +$8.2M 0.04% 360
2023
Q2 		$7.74M Buy
54,100
+37,650
+229% +$5.54M 0.03% 513
2023
Q1 		$2.28M Buy
16,450
+8,650
+111% +$1.16M 0.03% 647
2022
Q4 		$1.06M Sell
7,800
-950
-11% -$119K 0.02% 967
2022
Q3 		$960K Buy
+8,750
New +$1.11M 0.02% 1012
2019
Q2 		– Sell
-2,450
Closed -$198K – 1726
2019
Q1 		$198K Buy
+2,450
New +$193K 0.03% 786
2018
Q3 		$293K Buy
+3,700
New +$280K 0.14% 180

Other funds holding AZN

IA
Investor AB Stockholm, Sweden $15.1B AUM 29.02% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Legal & General Group
Legal & General Group London, United Kingdom $432B AUM 29.4% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
VAM
Vanguard Asset Management London, Ec4n 8af $117B AUM

Walleye Capital's AZN Position: Q1 2026 in Review

Walleye Capital reduced its AstraZeneca (AZN) stake by 100% in Q1 2026, selling an estimated $42M and leaving 1 share worth $197. The position accounts for ﹤0.01% of the portfolio, ranked #4287.

Walleye Capital first reported a position in AZN in Q1 2019 and has held it in 12 quarters since. The position peaked at $40M in Q4 2025. 1,377 funds tracked by Wall St. Rank hold AZN as of Q1 2026.

  • Walleye Capital held 1 share of AstraZeneca worth $197 as of Q1 2026.
  • Walleye Capital sold 217,697 AstraZeneca shares in Q1 2026, an estimated $42M.
  • AstraZeneca made up ﹤0.01% of Walleye Capital's portfolio in Q1 2026, its #4287 holding.
  • Walleye Capital first reported a position in AstraZeneca in Q1 2019 and has held it in 12 quarters since.
  • Walleye Capital's AstraZeneca position peaked at $40M in Q4 2025.
  • 1,377 funds tracked by Wall St. Rank held AstraZeneca as of Q1 2026.

Based on Walleye Capital's 13F filing for Q1 2026, filed 11 May 2026.